year
sinc
lysosom
discov
sinc
hydrolyt
machineri
includ
proteas
hydrolas
fairli
well
identifi
character
among
cystein
cathepsin
member
famili
papainlik
cystein
proteas
uniqu
reactivesit
properti
uneven
tissuespecif
express
pattern
live
organ
activ
delic
balanc
express
target
zymogen
activ
inhibit
protein
inhibitor
degrad
specif
substrat
bind
site
smallmolecul
inhibitor
repertoir
crystal
structur
provid
new
tool
research
develop
uniqu
reactivesit
properti
made
possibl
confin
target
simpli
use
appropri
reactiv
group
epoxysuccinyl
still
domin
field
nitril
seem
appropri
warhead
view
cystein
cathepsin
lysosom
proteas
chang
clear
evid
local
cellular
compart
besid
involv
protein
turnov
build
import
part
endosom
antigen
present
togeth
grow
number
nonendosom
role
cystein
cathepsin
grow
also
knowledg
involv
diseas
cancer
rheumatoid
arthriti
among
other
final
cystein
cathepsin
import
regul
signal
molecul
unimagin
number
biolog
process
current
challeng
identifi
endogen
substrat
order
gain
insight
mechan
substrat
degrad
process
review
remark
advanc
taken
place
past
decad
present
articl
part
special
issu
entitl
proteolysi
year
discoveri
lysosom
christian
de
duve
discov
distinct
class
singl
popul
homogen
granul
contain
five
acid
hydrolas
propos
refer
granul
lysosom
rich
term
hydrolyt
enzym
find
hydrolas
act
differ
substrat
suggest
lysosom
also
known
suicid
bag
might
play
role
intracellular
digest
acid
ph
lysosom
discov
sever
cell
type
found
involv
degrad
extracellular
materi
taken
endocytosi
intracellular
materi
taken
autophagi
thu
short
time
lysosom
concept
quickli
accept
parallel
base
find
numer
lysosom
hydrolas
isol
character
mechan
action
establish
discoveri
ubiquitinproteasom
system
conclud
two
major
system
intracellular
protein
degrad
lysosom
system
ubiquitinproteasom
system
well
establish
endosomallysosom
system
numer
function
normal
patholog
process
includ
surviv
function
lysosom
system
protein
degrad
result
combin
random
limit
action
variou
proteas
also
term
peptidas
proteolyt
enzym
order
achiev
effici
degrad
biolog
macromolecul
within
lysosom
lysosom
contain
number
divers
hydrolas
includ
proteas
amylas
lipas
nucleas
among
approxim
known
lysosom
hydrolas
particular
import
aspart
serin
cystein
proteas
addit
aspart
cathepsin
cystein
cathepsin
key
role
among
lysosom
proteas
belong
clan
ca
cystein
peptidas
wide
distribut
among
live
organ
repres
one
investig
group
enzym
specif
member
famili
papainlik
enzym
largest
best
character
famili
cystein
peptidas
includ
among
other
papain
relat
plant
enzym
proteas
parasit
helminth
insecthomolog
papain
trematod
cystein
proteas
viral
proteas
lysosom
cystein
cathepsin
chapter
focu
human
cystein
cathepsin
subject
numer
review
past
name
cathepsin
deriv
greek
kathepsein
digest
propos
proteas
activ
slightli
acid
environ
later
name
cathepsin
introduc
serin
proteas
cathepsin
g
aspart
proteas
cathepsin
e
lysosom
cystein
cathepsin
human
cystein
cathepsin
ie
cathepsin
b
c
f
h
k
l
v
x
w
exist
sequenc
level
confirm
bioinformat
analysi
draft
sequenc
human
genom
lysosom
cathepsin
requir
reduc
slightli
acid
environ
found
lysosom
order
optim
activ
therefor
cystein
cathepsin
initi
consid
intracellular
enzym
respons
nonspecif
bulk
proteolysi
acid
environ
endosomallysosom
compart
degrad
intracellular
extracellular
protein
howev
view
rapidli
chang
major
cathepsin
ubiquit
express
human
tissu
cathepsin
b
h
l
c
x
f
v
express
profil
indic
enzym
involv
normal
cellular
protein
degrad
turnov
contrast
cathepsin
k
w
show
restrict
cell
tissuespecif
distribut
indic
specif
role
exampl
cathepsin
k
highli
express
osteoclast
epitheli
cell
synovi
fibroblast
rheumatoid
arthriti
joint
among
matrixdegrad
enzym
cathepsin
k
enzym
essenti
role
bone
resorpt
unambigu
document
mice
human
cathepsin
w
also
lymphopain
predominantli
express
lymphocyt
natur
killer
nk
cell
howev
cathepsin
w
express
downregul
use
shrna
approach
essenti
role
process
cytotox
exclud
cathepsin
predominantli
express
profession
antigenpres
cell
apc
dendrit
cell
dc
bcell
addit
cathepsin
v
also
name
highli
homolog
cathepsin
l
contrast
ubiquit
express
cathepsin
l
express
restrict
thymu
testi
howev
recent
studi
shown
activ
cathepsin
also
local
cellular
compart
nucleu
cytoplasm
plasma
membran
thu
shown
catalyt
activ
cathepsin
l
variant
local
nucleu
play
role
regul
cellcycl
progress
proteolyt
process
nterminu
histon
tail
addit
shown
interact
histon
proteas
inhibitor
stefin
b
studi
nuclear
local
cathepsin
f
possibl
cathepsin
provid
first
evid
histon
may
import
substrat
cathepsin
thu
open
new
role
enzym
moreov
suffici
evid
specif
physiolog
function
cathepsin
might
least
partial
attribut
differ
local
insid
outsid
cell
consist
recent
advanc
field
proteas
led
new
concept
base
proteas
import
signal
molecul
involv
control
mechan
mani
normal
patholog
process
cystein
cathepsin
optim
activ
slightli
acid
ph
mostli
unstabl
neutral
ph
cathepsin
outsid
lysosom
extracellularli
rel
rapidli
irrevers
inactiv
neutral
ph
except
cathepsin
stabl
neutral
slightli
alkalin
ph
thu
retain
activ
inactiv
cathepsin
l
unstabl
cathepsin
neutral
ph
found
firstord
process
rate
process
decreas
substrat
concentr
confer
protect
cathepsin
b
irrevers
loss
activ
accompani
structur
chang
observ
enzym
destabil
increas
ionic
strength
content
organ
solvent
howev
bind
heparin
cathepsin
b
interact
occlud
loop
enzym
partial
protect
alkalinephinduc
inactiv
consequ
restrict
enzym
flexibl
make
stronger
contact
within
molecul
addit
recent
suggest
catalas
may
particip
protect
extracellular
cystein
cathepsin
peroxid
extracellular
local
cystein
cathepsin
often
coincid
increas
express
andor
activ
indic
ph
sole
factor
respons
activ
twenti
year
ago
demonstr
cathepsin
b
normal
tumor
tissu
degrad
purifi
extracellularmatrix
compon
type
iv
collagen
laminin
fibronectin
acid
neutral
ph
cathepsin
strong
elastolyt
collagenolyt
activ
known
chiefli
respons
remodel
extracellular
matrix
ecm
thu
contribut
variou
patholog
ecm
consist
elastin
collagen
proteoglycan
identifi
cathepsin
substrat
elastin
found
cleav
cathepsin
k
l
f
v
b
although
differ
elastolyt
activitiy
cathepsin
v
thu
found
potent
enzym
follow
cathepsin
k
f
l
b
demonstr
elastolyt
activ
cathepsin
v
k
could
inhibit
ubiquit
express
glycosaminoglycan
gag
chondroitin
sulfat
format
cathepsingag
complex
contrast
cathepsin
form
complex
chondroitin
sulfat
inhibit
thu
suggest
might
exist
specif
regul
elastolyt
activ
cathepsin
gag
potent
mammalian
collagenas
cathepsin
k
also
known
cathepsin
contrast
cathepsin
b
l
highli
express
osteoclast
suggest
play
special
role
bone
resorpt
normal
patholog
condit
cathepsin
k
form
collagenolyt
highli
activ
complex
gag
differ
gag
compet
bind
enzym
chondroitin
keratan
sulfat
enhanc
collagenolyt
activ
cathepsin
k
wherea
heparan
sulfat
heparin
select
inhibit
activ
moreov
gag
potenti
inhibit
collagenas
activ
cathepsin
l
addit
specif
inhibit
collagenas
activ
cathepsin
k
neg
charg
polym
polyglutam
oligonucleotid
without
affect
overal
proteolyt
activ
proteas
observ
suggest
interact
cathepsin
k
polym
collagen
degrad
specif
inhibit
noncollagenolyt
activ
remain
unchang
although
major
evid
variou
protein
degrad
vitro
cathepsin
acid
ph
scarc
data
intracellular
physiolog
substrat
one
main
reason
cathepsin
instabl
loss
activ
due
irrevers
unfold
first
wellestablish
intracellular
substrat
cathepsin
proapoptot
homolog
protein
bid
initi
found
process
lysosom
extract
therebi
trigger
cytochrom
c
releas
mitochondria
apoptosi
signific
redund
among
cathepsin
cleav
bid
vitro
experi
cellfre
system
bid
found
effici
process
cathepsin
b
k
l
h
proapoptot
form
find
confirm
variou
cellular
model
moreov
found
addit
bid
cathepsin
simultan
degrad
antiapoptot
famili
protein
bclxl
xiap
therebi
trigger
apoptosi
synergist
manner
howev
numer
biolog
process
cathepsin
play
import
role
substrat
identifi
far
part
review
focu
wellknown
basic
properti
cystein
cathepsin
present
elsewher
understand
interact
cystein
cathepsin
substrat
remain
main
challeng
research
cystein
cathepsin
papain
serv
model
pioneer
work
schechter
berger
propos
nomenclatur
posit
substrat
residu
p
subsit
bind
surfac
proteas
posit
subsit
number
direct
scisil
bond
residu
onward
nonprim
side
refer
ntermin
part
prime
side
ctermin
part
substrat
pioneer
work
found
ad
residu
peptid
longer
alanin
residu
affect
kinet
degrad
conclud
seven
substrat
residu
bind
seven
subsit
three
decad
later
revis
definit
substrat
bind
site
use
insight
provid
crystal
structur
complex
smallmolecul
substratemimick
inhibitor
structur
show
substrat
bind
along
activesit
cleft
extend
conform
fig
cystein
cathepsin
exhibit
broad
specif
thu
cleav
substrat
preferenti
basic
hydrophob
residu
true
synthet
also
protein
substrat
consist
role
intracellular
protein
degrad
inform
specif
mostli
gather
casebycas
basi
limit
applic
nevertheless
within
past
decad
substanti
progress
made
way
understand
specif
cystein
cathepsin
varieti
approach
appli
studi
case
specif
util
extract
new
knowledg
crystal
structur
papain
cystein
proteas
carica
papaya
among
first
dozen
protein
crystal
structur
determin
togeth
actinidin
two
structur
provid
first
insight
threedimension
structur
later
develop
enabl
isol
cystein
cathepsin
cathepsin
b
h
l
x
c
variou
tissu
rest
cathepsin
express
variou
express
system
crystal
structur
human
cathepsin
b
determin
follow
cathepsin
l
k
h
x
v
c
f
sequenc
align
matur
form
nine
cystein
cathepsin
known
structur
exhibit
conserv
activesit
residu
cathepsin
l
number
residu
interact
main
chain
bound
substrat
nterminu
certain
cy
residu
well
fig
even
though
structur
remain
two
human
cystein
cathepsin
w
still
unknown
sequenc
align
carri
independ
use
crystal
structur
human
cathepsin
l
templat
show
conserv
pattern
fig
papain
fold
shown
fig
use
cathepsin
l
typic
repres
cystein
cathepsin
endopeptidas
compos
two
domain
refer
left
l
right
r
accord
standard
view
ldomain
contain
three
longest
ie
vertic
helix
known
also
central
helix
residu
long
rdomain
kind
front
strand
form
coil
structur
bottom
barrel
enclos
reactiv
site
histidin
locat
top
sheet
form
barrel
twodomain
interfac
open
top
form
activesit
cleft
center
reactiv
site
residu
come
differ
domain
reactiv
site
cystein
locat
nterminu
central
helix
ldomain
wherea
histidin
locat
within
residu
rdomain
two
catalyt
residu
form
thiolateimidazolium
ion
pair
essenti
proteolyt
activ
enzym
activesit
surfac
compos
residu
come
four
loop
locat
domain
fig
two
ldomain
loop
short
crossconnect
disulfid
bond
two
rdomain
loop
much
larger
form
lid
hydrophob
core
substrat
bind
along
activesit
cleft
extend
conform
side
chain
make
altern
contact
land
rdomain
two
loop
ldomain
fig
schemat
represent
substratebind
site
papainlik
proteas
along
activesit
cleft
represent
base
propos
revis
definit
substratebind
site
base
crystal
structur
substratemimick
inhibitor
bound
proteas
activ
site
substratebind
site
papainlik
proteas
locat
left
right
side
activesit
cleft
accord
standard
view
orient
accord
papain
number
ldomain
loop
includ
residu
wherea
rdomain
loop
contain
residu
respect
activesit
residu
disulphid
indic
pdb
code
structur
follow
cathepsin
b
cathepsin
c
cathepsin
f
cathepsin
h
cathepsin
k
cathepsin
l
cathepsin
cathepsin
v
cathepsin
x
papain
accord
cathepsin
l
number
residu
form
substratebind
site
within
ldomain
loop
rdomain
loop
box
highlight
light
gray
b
structurebas
sequenc
align
human
cathepsin
w
guid
use
known
structur
human
cathepsin
l
use
expresso
program
case
lead
sequenc
human
cathepsin
l
shown
uppercas
letter
wherea
nonconserv
residu
indic
lowercas
letter
ident
residu
shown
dot
gap
mark
dash
symbol
activ
site
residu
indic
asterisk
bridg
interfac
provid
surfac
side
chain
residu
wherea
loop
residu
rdomain
provid
bind
surfac
residu
except
residu
accord
model
residu
interact
domain
mainchain
atom
form
antiparallel
hydrogenbond
ladder
sidechain
atom
bind
pocket
form
twodomain
interfac
altern
posit
side
chain
suggest
may
cooper
effect
residu
orient
toward
surfac
particular
appear
close
enough
abl
interact
howev
experiment
evid
latter
still
lack
cystein
cathepsin
exhibit
predominantli
endopeptidas
activ
wherea
cathepsin
x
c
exopeptidas
cathepsin
c
aminodipeptidas
cathepsin
h
addit
endopeptidas
aminopeptidas
cathepsin
b
endopeptidas
carboxydipeptidas
wherea
cathepsin
x
carboxymonopeptidas
crystal
structur
reveal
exopeptidas
contain
addit
structur
featur
modifi
activesit
cleft
fig
wherea
endopeptidas
cathepsin
f
l
k
v
activesit
cleft
extend
along
whole
length
twodomain
interfac
exopeptidas
cathepsin
b
c
h
x
addit
featur
reduc
number
bind
site
case
carboxypeptidas
substrat
bind
govern
loop
fill
activesit
cleft
prime
side
loop
carboxypeptidas
occlud
loop
cathepsin
b
miniloop
cathepsin
x
util
histidin
residu
dock
ctermin
carboxyl
group
peptidyl
substrat
contrast
cathepsin
h
c
util
region
propeptid
part
order
provid
featur
fill
activesit
cleft
nonprim
side
use
carboxyl
group
mainand
sidechain
residu
dock
posit
charg
nterminu
peptidyl
substrat
cathepsin
h
carboxyl
group
locat
cterminu
eightresidueslong
peptid
part
propeptid
term
minichain
remain
attach
bodi
enzym
activ
howev
cathepsin
c
carboxyl
group
come
side
chain
posit
nterminu
whole
addit
domain
call
exclus
domain
fill
activesit
cleft
interestingli
aminopeptidas
glycosyl
appear
crucial
stabil
structur
addit
featur
simultan
fill
activesit
cleft
tighten
substrat
bind
exopeptidas
addit
featur
insert
endopeptidas
scaffold
defin
mani
residu
bind
prime
nonprim
side
activesit
cleft
understand
prefer
peptidyl
substrat
side
chain
significantli
subtl
matter
structur
shown
substrat
bind
activesit
cleft
extend
conform
superposit
structur
provid
support
three
welldefin
substrat
bind
site
substrat
residu
interact
enzym
mainand
sidechain
interact
fig
among
site
form
pocket
posit
outsid
region
sidechain
interact
spread
residu
posit
across
activesit
cleft
nonprim
side
demonstr
bind
site
realli
site
appropri
describ
area
substrat
residu
individu
find
favor
bind
posit
prime
bind
side
still
limit
structur
insight
substrat
bind
data
provid
synthet
epoxysuccinylbas
inhibitor
complex
cathepsin
b
bind
reveal
posit
residu
howev
inform
therein
also
limit
one
hand
redund
residu
essenti
structur
hand
inform
bias
residu
dock
ctermin
carboxyl
group
side
chain
posit
within
occlud
loop
cathepsin
b
sinc
occlud
loop
specif
cathepsin
b
cathepsin
posit
residu
may
differ
henc
three
defin
substrat
bind
site
amino
acid
residu
substrat
interact
mainand
sidechain
atom
surfac
enzym
fig
case
cathepsin
b
mainchain
interact
offer
occlud
loop
histidin
other
recogniz
expos
residu
provid
serv
dock
mainchain
atom
substrat
residu
beyond
therefor
site
recommend
term
area
clearli
absenc
dock
partner
mainchain
atom
bind
area
provid
opportun
differ
binder
may
howev
reduc
select
substrat
substrat
specif
proteas
delic
interplay
interact
surfac
proteas
substrat
studi
tri
reveal
interplay
base
two
shown
green
ribbon
represent
part
correspond
secondari
structur
element
shown
blue
red
color
respect
side
chain
reactivesit
cystein
histidin
indic
ballandstick
represent
complementari
approach
studi
structurefunct
relationship
ii
studi
substrat
specif
combin
two
approach
use
past
year
tackl
specif
cystein
cathepsin
target
protein
first
approach
residu
interest
locat
sequenc
structur
proteas
mutat
reveal
relev
role
certain
interact
second
approach
enzym
left
intact
substrat
manipul
size
composit
synthet
substrat
includ
natur
occur
amino
acid
residu
well
nonnatur
amino
acid
residu
within
frame
studi
also
degrad
studi
true
protein
substrat
proteom
approach
latter
increas
import
vitro
experi
get
close
natur
occur
event
current
possibl
although
consider
inform
proteas
function
gain
structurefunct
relationship
studi
cystein
cathepsin
mainli
perform
use
substratespecif
approach
major
studi
perform
mostli
focus
cathepsin
b
first
cathepsin
crystal
structur
determin
structur
enzym
reveal
part
pocket
form
uniqu
residu
found
cathepsin
b
cathepsin
mutat
glutamin
show
import
process
substrat
arginin
posit
effect
phenylalanin
substrat
anoth
exampl
mutat
site
cathepsin
b
made
site
favor
glycin
correspond
glycinefavor
papaya
proteas
iv
glycyl
endopeptidas
although
entir
link
subsit
specif
mutat
histidin
residu
occlud
loop
well
delet
loop
reveal
import
loop
two
histidin
residu
endopeptidas
activ
cathepsin
b
similar
attempt
made
understand
differ
site
cathepsin
l
k
doubl
mutat
pocket
cathepsin
k
l
induc
switch
enzym
specif
toward
small
select
inhibitor
peptidyl
substrat
confirm
crucial
role
residu
posit
howev
mutant
cathepsinklik
cathepsin
l
well
cathepsinllik
cathepsin
k
capabl
degrad
collagen
indic
introduc
prolin
toler
alon
convert
cathepsin
l
collagenas
abolish
prolin
select
cathepsin
k
prevent
degrad
collagen
similar
followup
studi
address
cathepsin
k
chondroitin
bind
site
exampl
studi
demonstr
basic
understand
specif
encod
structur
howev
understand
still
suffici
enabl
us
predict
select
substrat
base
sequenc
atom
structur
cystein
cathepsin
switch
vitro
biochem
studi
physiolog
studi
complex
biolog
millieu
access
highli
select
substrat
found
crucial
monitor
activ
individu
cystein
cathepsin
biolog
sampl
focu
substrat
studi
therefor
shift
discoveri
substrat
specif
individu
cathepsin
studi
use
peptidyl
librari
combin
posit
scan
individu
posit
mostli
one
time
survey
summari
exampl
indic
extens
research
past
decad
summari
organ
basi
individu
cathepsin
cathepsin
b
although
numer
studi
cathepsin
b
specif
perform
past
recent
highthroughput
studi
demonstr
arginin
inde
suitabl
residu
posit
moreov
base
screen
site
abzgivrak
dnp
oh
peptid
found
contain
favor
residu
cathepsin
b
cathepsin
x
develop
substrat
analysi
crucial
clarifi
cathepsin
x
carboxymonopeptidas
result
question
addit
dicarboxypeptidas
endopeptidas
activ
resolv
ambigu
like
result
presenc
impur
sampl
either
obtain
isol
natur
sourc
cathepsin
b
express
proform
leftov
cathepsin
l
activ
enzym
cathepsin
k
substrat
specif
cathepsin
k
also
extens
studi
enzym
import
drug
target
treatment
osteoporosi
among
mammalian
cystein
cathepsin
cathepsin
k
found
uniqu
prefer
prolin
residu
posit
primari
determin
substrat
specif
result
screen
highli
select
abzhpggpqeddnp
substrat
identifi
select
substrat
primarili
depend
site
specif
ioniz
state
histidin
posit
hydrolysi
complet
abolish
cathepsinkdefici
cell
lysat
indic
use
monitor
cathepsin
k
activ
physiolog
fluid
cell
lysat
anoth
screen
site
specif
use
abzklrfskqeddnp
templat
show
requir
site
restrict
site
addit
found
posit
charg
residu
favor
posit
glycin
almost
equal
well
accept
site
posit
charg
residu
readili
accept
wherea
site
less
pronounc
prefer
howev
prolin
use
posit
confer
specif
cathepsin
k
cathepsin
screen
cathepsin
use
templat
base
ii
sequenc
clear
prefer
group
amino
acid
residu
observ
posit
base
result
highli
cathepsinsselect
peptid
develop
basi
author
suggest
observ
cleavag
site
ii
might
relev
vivo
process
followup
studi
shown
specif
cathepsin
mainli
determin
site
posit
hydrophob
valin
methionin
norleucin
residu
clearli
prefer
similarli
hydrophob
branch
side
chain
prefer
posit
result
grwhtvglrweli
dnp
substrat
cleavag
site
claim
select
cathepsin
cathepsin
b
h
l
x
author
also
confirm
substrat
process
endosom
fraction
antigenpres
cell
abolish
presenc
lhv
morpholinurealeucinehomophenylalaninvinyl
sulfonephenyl
select
inhibitor
cathepsin
similar
attempt
distinguish
cathepsin
cathepsin
substrat
deriv
basi
put
physiolog
substrat
ie
insulin
classiiassoci
invari
chain
clip
result
abzleqeddnp
abz
orthoaminobenzo
acid
eddnp
n
ethylenediamin
peptid
capabl
differenti
cathepsin
cathepsin
l
b
v
k
cathepsin
v
substrat
screen
made
use
cathepsin
l
v
found
cathepsin
v
site
exhibit
broad
specif
cathepsin
l
prefer
posit
charg
residu
posit
site
enzym
found
requir
hydrophob
residu
prefer
phe
leu
hand
site
cathepsin
found
less
specif
list
exampl
lack
systemat
approach
would
restrain
limit
variabl
substrat
composit
confin
list
target
use
select
process
howev
novel
approach
way
attempt
consider
less
restrain
substrat
select
highthroughput
proteom
studi
cathepsin
k
specif
use
oligopeptidyl
librari
deriv
natur
protein
unrestrain
length
peptid
screen
reveal
cathepsin
k
prefer
aspart
posit
specif
believ
relev
recognit
collagen
substrat
yet
anoth
way
determin
substrat
specif
cystein
cathepsin
use
peptid
phage
librari
recent
report
cathepsinllik
enzym
tick
rhipicephalu
boophilu
microplu
prefer
leucin
arginin
posit
similar
attempt
certainli
shed
light
novel
aspect
substrat
specif
cystein
cathepsin
discoveri
epoxysuccinylbas
inhibitor
ltransepoxysuccinylleucylamido
butan
import
research
cystein
cathepsin
select
alkyl
reactiv
site
cystein
remain
coval
bound
enzym
react
almost
exclus
reactiv
site
cystein
papainlik
proteas
immedi
becom
wide
use
indic
proteolyt
activ
cystein
cathepsin
togeth
deriv
improv
cellperm
properti
immens
import
progress
understand
function
properti
cystein
cathepsin
rang
titrat
activ
assess
activ
cell
lysat
cultur
live
organ
nonselect
inhibitor
cystein
cathepsin
except
cathepsin
c
weakli
inhibit
addit
also
effici
inhibit
calpain
exploit
scaffold
led
semin
contribut
katunuma
group
develop
first
specif
inhibitor
cathepsin
b
analog
crystal
structur
cathepsin
b
ethylest
epoxysuccinyllilelprooh
analog
later
complex
bovin
cathepsin
b
shown
inhibitor
bind
prime
side
site
activesit
cleft
direct
substrat
structur
confirm
carboxyl
group
prolin
inde
respons
bind
occlud
loop
histidin
held
respons
bind
ctermin
carboxyl
group
peptidyl
substrat
align
bind
geometri
indic
epoxysuccinyl
group
possess
intern
symmetri
two
ctermin
carboxyl
group
amino
acid
residu
attach
idea
use
epoxysuccinyl
build
block
allow
simultan
access
nonprim
well
prime
side
activesit
cleft
success
adopt
develop
inhibitor
cathepsin
b
well
inhibitor
cathepsin
k
l
predict
bind
geometri
doublehead
inhibitor
confirm
crystal
structur
papainclik
complex
model
cathepsin
l
cathepsin
complex
sever
detail
paper
subject
worthi
read
addit
use
epoxysuccinylbas
inhibitor
includ
activitybas
probe
develop
bogyo
group
mention
leupeptin
found
bacteria
anoth
inhibitor
known
aldehyd
coval
bind
nucleophil
serin
cystein
residu
activ
site
cystein
serin
proteas
due
proteaseclass
nonspecif
interact
less
wide
use
howev
reaction
activ
site
cystein
proteas
revers
allow
reactiv
enzym
attach
residu
provid
select
number
reactiv
group
also
call
warhead
interact
one
class
proteas
exampl
one
pioneer
synthesi
proteas
inhibitor
elliott
shaw
exploit
diazomethan
reactiv
group
coval
interact
activ
site
either
point
nonprim
region
case
epoxysuccinyl
group
extend
side
epoxysuccinyl
group
use
concept
inhibit
endopeptidas
see
well
carboxypeptidas
cathepsin
b
x
howev
aminopeptidas
cathepsin
c
h
concept
would
difficult
appli
due
two
ctermini
achiev
select
cathepsinc
dipeptidyl
construct
acyloxymethyl
keton
fluoromethyl
keton
vinyl
sulfon
therefor
develop
hand
select
cathepsin
h
would
confin
singl
bind
subsit
inhibitor
limit
select
also
synthes
use
chloroand
fluoromethyl
keton
reactiv
group
attach
singl
amino
acid
residu
endopetidas
carboxypeptidas
restraint
nonprim
side
activesit
cleft
appli
therefor
numer
develop
list
reactiv
group
use
rather
extens
acyloxymethyl
keton
vinyl
sulfon
nitril
azepanonebas
allylsulfon
inform
found
excel
overview
also
construct
extend
across
activesit
cleft
without
coval
interact
degrad
eg
cyclic
keton
late
nitril
shown
give
best
result
also
use
clinic
candid
versatil
smallmolecul
compound
confin
like
peptidyl
substrat
directli
address
subsit
specif
term
biolog
function
role
cystein
cathepsin
therefor
review
attempt
provid
indepth
look
select
mention
number
inhibitor
crystal
complex
cystein
cathepsin
structur
determin
present
deposit
structur
correspond
cathepsin
mainli
cystein
proteas
complex
smallmolecul
inhibitor
drugdiscoveri
process
predominantli
target
cathepsin
k
l
underway
develop
alreadi
enter
clinic
trial
activitybas
probe
abp
substanc
interact
activ
site
enzym
report
activ
sophist
chemistri
make
possibl
character
enzym
function
directli
nativ
biolog
system
abp
usual
carri
report
biotin
quencherfluorophor
pair
get
activ
upon
reaction
target
enzym
fluoresc
probe
base
epoxysuccinyland
acyloxymethylketon
reactiv
group
enabl
imag
cell
well
noninvas
optic
imag
cathepsin
b
l
mice
addit
abp
cathepsin
x
also
becom
avail
recent
abp
target
cystein
proteas
suicid
inhibitor
remain
attach
enzym
form
coval
bond
reactiv
site
cystein
howev
novel
approach
term
revers
design
built
exist
select
inhibitor
cystein
cathepsin
subsequ
convers
substrat
activ
probe
proteas
vivo
establish
convers
inhibitor
cathepsin
k
replac
activesitedirect
function
electrophyl
group
peptidyl
unit
addit
fluorophor
quencher
result
cellperm
abp
reveal
endolysosom
local
cathepsin
l
studi
cathepsin
b
l
k
use
evalu
select
probe
due
nonsuicid
natur
activ
probe
physiolog
cell
investig
potenti
less
disturb
moreov
activitybas
probe
use
valid
effect
activitymodul
compound
drug
candid
cell
vivo
system
timedepend
manner
time
sinc
test
proteolyt
activ
base
degrad
insulin
nowaday
tri
understand
proteas
hydrolyz
physiolog
substrat
recent
knowledg
biolog
target
cystein
cathepsin
larg
come
identifi
origin
genet
disord
consequ
geneknockout
studi
signific
redund
cystein
cathepsin
due
coloc
broad
specif
although
cystein
cathepsin
specif
role
possess
proteolyt
potenti
cleav
number
substrat
howev
like
specif
role
link
specif
interact
proteas
substrat
exampl
cathepsin
b
h
k
l
cleav
kininogen
therebi
releas
kinin
peptid
howev
cathepsin
k
shown
abl
cleav
kinin
natur
occur
cleavag
site
support
idea
kept
mind
cystein
cathepsin
coloc
therefor
work
concert
due
limit
specif
nonredund
role
could
reveal
confirm
absenc
particular
cathepsin
made
attempt
divid
protein
substrat
hydrolysi
classic
ie
confin
endosomeslysosom
secretori
lysosom
nonclass
ie
take
place
outsid
organel
correspondingli
name
substrat
seen
apart
cathepsin
role
antigen
present
granul
proteas
activ
specif
physiolog
role
investig
take
place
nonclass
locat
environ
among
collagen
degrad
cathepsin
k
thyroglobulin
process
thyroid
hormon
releas
variou
cathepsin
histon
process
mous
cathepsin
l
role
cathepsin
x
integrin
process
tcell
signal
rather
simpl
mechan
classic
pathway
appear
cathepsin
c
interact
substrat
role
gradual
remov
two
consecut
residu
protein
ntermini
shown
geneknockout
studi
number
serin
proteas
immun
inflammatori
cell
activ
cathepsin
c
granul
way
cystein
cathepsin
also
play
crucial
role
adapt
immun
cathepsin
crucial
process
invari
chain
bonemarrowderiv
antigenpres
cell
dendrit
cell
macrophag
human
v
mous
l
requir
ii
process
thymu
addit
cathepsin
gener
peptid
present
mhc
classii
molecul
cathepsin
l
found
indispens
gener
specif
peptid
repertoir
cortic
thymic
epitheli
cell
requir
cell
posit
select
thymu
consid
role
cathepsin
attempt
made
reveal
substrat
specif
cathepsin
screen
peptid
librari
purpos
valid
pattern
cleavag
site
ii
polypeptid
compar
result
peptid
librari
screen
surprisingli
similar
found
howev
cleavag
site
invari
chain
numer
question
remain
whether
cathepsin
simpli
chop
ii
smaller
peptid
cathepsin
perform
specif
cleavag
sinc
cathepsin
vl
found
crucial
process
thymu
mhc
classii
ii
complex
evid
sever
proteas
job
recent
new
pathway
prohormon
process
mediat
secretori
vesicl
cathepsin
l
describ
glycosaminoglycan
play
crucial
role
format
complex
cystein
cathepsin
protein
substrat
gag
thu
shown
regul
collagenolyt
activ
human
cystein
cathepsin
furthermor
collagenas
activ
cathepsin
k
complex
format
chondroitin
sulfat
mandatori
cartilag
cathepsin
k
alon
capabl
provid
sourc
gag
remov
aggrecan
insight
mechan
rather
uniqu
relationship
reveal
crystal
structur
chondroitin
sulfatecathepsin
k
complex
accompani
biochem
studi
crystal
sever
cathepsin
k
molecul
bind
singl
chondroitin
sulfat
site
distant
activ
site
work
suggest
cathepsin
khydrolysi
collagen
role
chondroitin
sulfat
bring
togeth
align
sever
cathepsin
k
molecul
way
make
possibl
cleavag
tripl
collagen
helix
chondroitin
thu
provid
scaffold
associ
cathepsin
k
molecul
effect
share
cathepsin
l
mutat
cathepsin
k
modifi
chondroitin
bind
site
cathepsin
k
cathepsinllik
decreas
collagenolyt
activ
protein
crystal
structur
complex
cathepsinllik
cathepsin
k
chondroitin
sulfat
latter
still
bind
cathepsin
k
howev
way
structur
nativ
cathepsin
k
summar
studi
reveal
relev
chondroitin
sulfat
bind
cathepsin
k
collagen
proteolysi
nevertheless
modifi
bind
site
chondroitin
cathepsinllik
remov
collagenas
activ
indic
cathepsin
k
possess
addit
featur
enabl
cleav
collagen
effici
gelatin
partial
degrad
unfold
collagen
howev
cleav
sever
cathepsin
similarli
cathepsin
l
releas
gag
cartilag
protein
aggrecan
evid
cathepsin
l
particip
bone
resorpt
find
suggest
number
cathepsin
particip
bone
resorpt
remodel
howev
shown
cathepsin
k
presenc
organ
vital
osteoclast
resorpt
inhibit
strong
potenti
treat
osteoporosi
quit
possibl
cathepsin
capabl
unwind
collagen
tripl
helix
insight
activ
cathepsin
k
provid
kinet
spectroscop
studi
provid
evid
two
state
cathepsin
k
depend
ph
media
reminisc
cathepsin
b
exoand
endopeptidyl
activ
believ
result
dissoci
ioniz
group
bind
cleft
structur
cathepsin
b
becam
avail
evid
occlud
loop
must
displac
order
enabl
endopeptidas
activ
enzym
final
confirm
mutat
occlud
loop
includ
remov
part
contrast
exopeptidas
cathepsin
b
cathepsin
k
fold
provid
obviou
structur
featur
surfac
cathepsin
k
would
trigger
chang
state
therebi
affect
substrat
kinet
phdepend
manner
possibl
mechan
oligomer
cathepsin
k
exclud
experiment
data
howev
remain
open
whether
behavior
consist
model
cathepsin
k
form
bead
string
structur
earlier
suggest
anoth
exampl
shed
light
substrat
hydrolysi
cathepsin
hormon
releas
degrad
thyroglobulin
despit
gener
belief
contrari
shown
cathepsin
capabl
process
thyroglobulin
neutral
oxid
condit
cathepsin
b
k
l
thu
found
gener
distinct
fragment
thyroglobulin
moreov
thyroid
hormon
thyroxin
liber
action
cathepsin
extracellular
condit
cathepsin
b
k
l
effici
endolysosom
condit
suggest
biolog
role
proteas
may
depend
local
environ
yet
anoth
nonclass
role
involv
cathepsin
l
cleavag
histon
nucleu
base
assumpt
rather
specif
interact
anticip
bind
model
substrat
peptid
activ
site
might
provid
insight
specif
interact
rather
long
peptid
deriv
histon
sequenc
therefor
cocrystal
inact
mutant
human
cathepsin
l
howev
bind
three
residu
nonprim
bind
site
cathepsin
l
surfac
could
satisfactorili
resolv
nevertheless
work
encourag
attempt
gain
detail
structur
insight
interact
cystein
cathepsin
physiolog
substrat
cathepsin
also
found
particip
process
modul
tcell
migrat
process
combin
cathepsin
target
outsid
endosom
subsequ
proteolysi
target
locat
extracellular
function
cathepsin
x
enzym
suggest
involv
process
may
includ
bind
integrin
via
rgd
motif
proregion
suggest
activ
mechan
enzym
locat
outsid
endosom
suggest
attach
migrat
cell
extracellular
matrix
compon
modul
moreov
cathepsin
x
found
cleav
integrin
therebi
demonstr
anoth
way
regul
tcell
migrat
indic
cathepsin
x
remov
ctermin
residu
integrin
therebi
increas
affin
adaptor
protein
talin
subsequ
cleavag
result
intermedi
well
highaffin
intermedi
affin
form
associ
highaffin
form
crucial
tcell
migrat
although
describ
detail
cystein
cathepsin
shown
particip
regul
antimicrobi
molecul
inactiv
secretori
leucoproteas
inhibitor
even
though
part
disput
process
virus
cathepsin
l
process
corona
viru
normal
condit
healthi
organ
cell
use
variou
mechan
prevent
potenti
harm
uncontrol
proteolyt
activ
includ
compartment
cathepsin
within
lysosom
organel
zymogen
activ
ph
regul
activ
smallmolecul
inhibitor
variou
endogen
protein
inhibitor
combin
factor
optim
enzym
function
lysosom
cathepsin
contribut
process
irrevers
cleavag
peptid
bond
limit
random
proteolysi
accompani
protein
degrad
remaind
review
focu
zymogen
activ
regul
protein
inhibitor
although
aspect
also
discuss
lysosom
cathepsin
synthes
preproenzym
cleavag
ntermin
signal
peptid
occur
passag
endoplasm
reticulum
parallel
nlink
glycosyl
remov
signal
peptid
propeptid
assist
proper
fold
enzym
target
endosom
lysosom
use
specif
receptor
pathway
simultan
act
inhibitor
prevent
inappropri
proteolyt
activ
zymogen
dissoci
bound
immatur
occur
mildli
acid
environ
endosom
remov
ntermin
propeptid
matur
proteolyt
activ
cathepsin
releas
matur
enzym
occur
singlechain
doublechain
form
without
affect
catalyt
activ
twochain
enzym
remain
connect
disulphid
bridg
progress
understand
natur
zymogen
activ
obtain
procathepsin
structur
crystal
structur
human
rat
procathepsin
b
human
procathepsin
l
human
procathepsin
k
human
procathepsin
x
show
propeptid
chain
fold
surfac
enzym
extend
conform
run
activesit
cleft
opposit
direct
substrat
therebi
block
access
latter
activ
site
alreadi
form
zymogen
fig
structur
proenzym
hydrophob
interact
salt
bridg
hydrogenbond
interact
propeptid
propeptid
matur
enzym
exist
except
structur
cathepsin
x
propeptid
bind
coval
matur
enzym
disulphid
bridg
cystein
residu
propeptid
activesit
cystein
thu
prevent
autocatalyt
process
howev
process
vitro
reduc
condit
cathepsin
l
cathepsin
proteolyt
remov
ntermin
propeptid
result
activ
enzym
catalyz
differ
proteas
cathepsin
variou
cystein
proteas
autocatalyt
acid
condit
earli
studi
suggest
autocatalyt
process
unimolecular
process
other
propos
interand
intramolecular
mechan
enigma
recent
clarifi
clear
autoactiv
cathepsin
combin
unimolecular
bimolecular
process
procathepsin
b
possess
low
catalyt
activ
nevertheless
suffici
trigger
autocatalyt
activ
zymogen
activ
result
propeptid
dissoci
activesit
cleft
first
step
process
fact
unimolecular
step
process
next
step
alreadi
bimolecular
catalyt
activ
zymogen
molecul
process
activ
anoth
procathepsin
molecul
one
step
matur
cathepsin
molecul
gener
way
initi
chain
reaction
lead
rapid
activ
remain
procathepsin
molecul
taken
togeth
endopeptidas
cathepsin
b
h
l
k
activ
remov
propeptid
wherea
true
exopeptidas
cathepsin
c
x
requir
endopeptidas
cathepsin
l
activ
autocatalyt
activ
cathepsin
substanti
acceler
presenc
neg
charg
molecul
gag
dextran
sulfat
suggest
gag
involv
vivo
process
cathepsin
similarli
gag
acceler
autocatalyt
remov
propeptid
subsequ
activ
cathepsin
b
find
suggest
gag
may
play
physiolog
role
activ
procathepsin
b
result
confirm
autocatalyt
activ
procathepsin
presenc
gag
propeptid
remov
process
cystein
cathepsin
shown
potent
inhibitor
cognat
enzym
vitro
first
exampl
synthet
propeptid
cathepsin
b
found
inhibit
cathepsin
b
ph
k
nm
wherea
ph
inhibit
much
weaker
suggest
activ
acid
ph
propeptid
dissoci
surfac
enzym
therebi
facilit
activ
later
experiment
confirm
subsequ
recombin
cathepsin
l
propeptid
found
inhibit
cathepsin
l
k
nm
cathepsin
k
nm
wherea
inhibit
cathepsin
b
papain
observ
provid
first
evid
propeptid
act
select
cathepsin
inhibitor
studi
confirm
find
demonstr
propeptid
exhibit
limit
select
inhibit
cognat
enzym
moreov
cathepsin
propeptid
found
rapidli
degrad
cathepsin
l
latter
link
acid
phinduc
unfold
dissoci
procathepsin
b
propeptid
suggest
propeptid
releas
zymogen
activ
degrad
result
lose
inhibitori
role
howev
note
procathepsin
structur
propeptid
coval
bound
enzym
fig
wherea
vitro
studi
mention
perform
isol
peptid
therefor
studi
necessarili
reflect
vivo
situat
indepth
inform
structur
aspect
function
propeptid
see
spite
similar
biolog
function
propeptid
cystein
cathepsin
show
littl
similar
amino
acid
sequenc
strike
contrast
strong
overal
homolog
major
matur
form
howev
probabl
explain
need
select
inhibit
cognat
enzym
traffick
endolysosom
compart
subsequ
degrad
process
prevent
sustain
inhibit
cathepsin
lysosom
sequenc
analys
famili
papainlik
cystein
proteas
led
recognit
two
distinct
subfamili
design
cathepsinllik
cathepsinblik
proteas
distinguish
propeptid
matur
enzym
structur
main
differ
subfamili
exist
sequenc
propeptid
length
propeptid
cathepsin
l
subfamili
cathepsin
l
v
k
w
f
h
contain
propeptid
residu
two
conserv
motif
highli
conserv
erfnin
motif
gnfd
motif
former
lack
cathepsin
b
subfamili
propeptid
cathepsin
c
x
lack
erfnin
motif
propeptid
cathepsin
x
contain
residu
shortest
cathepsin
contrast
cathepsin
f
propeptid
residu
longest
human
cathepsin
contain
addit
ntermin
cystatinlik
domain
propeptid
cathepsin
c
contain
residu
interestingli
remov
propeptid
residu
proteolyt
activ
remain
residu
becom
part
structur
matur
cathepsin
c
respons
dipeptidyl
peptidas
activ
known
exclus
domain
major
regul
matur
cystein
cathepsin
endogen
protein
inhibitor
cystatin
thyropin
serpin
among
other
basic
competit
revers
tightbind
inhibitor
prevent
substrat
bind
activ
site
basic
principl
kinet
interact
inhibitor
proteas
well
physiolog
role
discuss
short
base
physiolog
role
divid
emerg
regulatori
inhibitor
typic
emerg
inhibitor
cystatin
separ
target
enzym
primarili
act
escap
proteas
proteas
invad
pathogen
also
demonstr
thyropin
regulatori
inhibitor
block
also
modul
proteas
activ
moreov
often
coloc
target
enzym
classifi
thresholdtyp
buffertyp
delaytyp
inhibitor
buffertyp
inhibitor
keep
proteas
complex
absenc
substrat
releas
presenc
substrat
thu
prevent
inappropri
proteolysi
propeptid
lysosom
cathepsin
like
belong
type
inhibitor
review
four
type
inhibitor
emerg
threshold
buffer
delay
import
keep
necessari
balanc
normal
physiolog
condit
first
classif
protein
inhibitor
papainlik
cystein
proteas
cystatin
superfamili
three
famili
base
protein
homolog
chicken
cystatin
first
inhibitori
protein
known
amino
acid
sequenc
addit
close
sequenc
relationship
least
sequenc
ident
new
criteria
includ
absenc
presenc
two
nine
disulphid
bond
howev
rapidli
increas
number
cystatin
variou
origin
result
new
divis
four
type
basi
presenc
one
two
three
copi
cystatinlik
domain
presenc
absenc
disulphid
bond
first
three
type
name
stefin
cystatin
kininogen
inhibitori
protein
fourth
type
consist
noninhibitori
homolog
cystatin
fetuin
histidinerich
glycoprotein
contain
two
cystatinlik
domain
howev
evolut
lost
inhibitori
activ
due
mutat
structur
import
region
import
step
introduct
merop
databas
integr
sourc
inform
firstli
peptidas
protein
peptidas
inhibitor
singl
system
nomenclatur
basi
similar
amino
acid
sequenc
level
threedimension
structur
introduc
group
clan
famili
individu
inhibitor
correspondingli
cystatin
famili
assign
three
subfamili
clan
ih
thyropin
assign
famili
clan
ix
classif
protein
peptidas
inhibitor
continu
revis
seen
merop
websit
http
meropssangeracuk
therefor
cystatin
discuss
group
type
conveni
respect
present
statu
field
stefin
singlechain
protein
amino
acid
residu
synthes
without
signal
peptid
lack
carbohydr
disulphid
bond
primarili
intracellular
protein
also
detect
bodi
fluid
stefin
present
major
eukaryot
subgroup
origin
two
repres
group
stefin
b
found
variou
mammal
includ
human
addit
bovin
stefin
c
identifi
first
trpcontain
stefin
prolong
nterminu
stefin
belong
subfamili
cystatin
protein
famili
cystatin
wide
distribut
protein
stefin
singlechain
protein
amino
acid
residu
contrast
stefin
cystatin
contain
signal
peptid
respons
secret
cell
membran
extracellular
milieu
recogn
extracellular
protein
current
seven
member
type
inhibitor
identifi
cystatin
c
salivari
cystatin
cystatin
sa
sn
cystatin
cystatin
em
cystatin
f
leukocystatin
type
cystatin
contain
two
highli
conserv
intramolecular
disulphid
bridg
except
human
cystatin
f
possess
addit
disulphid
bridg
thu
stabil
ntermin
part
protein
human
type
cystatin
group
subfamili
cystatin
famili
kininogen
known
sever
decad
precursor
molecul
kinin
found
predominantli
blood
plasma
mammal
speci
although
kinin
could
releas
two
major
pathway
involv
either
plasma
kallikreinkinin
system
tissu
kallikrein
altern
rout
may
involv
cystein
cathepsin
kininogen
multifunct
multidomain
glycoprotein
compris
three
distinct
type
highmolecularweight
kininogen
hk
lowmolecularweight
kininogen
lk
tkininogen
tk
acut
phase
protein
found
rat
human
hk
lk
product
gene
result
altern
mrna
splice
tk
encod
tkgene
matur
kininogen
singlechain
protein
multipl
domain
cleavag
kallikrein
releas
kinin
segment
convert
twochain
protein
heavyand
lightchain
heavi
chain
hk
lk
ident
amino
acid
sequenc
wherea
lightchain
hk
much
longer
lk
molecular
mass
lk
kda
kda
hk
heavi
chain
hk
lk
compos
three
tandemli
repeat
type
cystatinlik
domain
domain
contain
eight
disulphid
bridg
second
third
domain
inhibit
papainlik
proteas
inhibitori
domain
close
relat
domain
hk
lk
bind
two
molecul
variou
cystein
proteas
includ
cathepsin
cruzipain
high
affin
contrast
vitro
studi
show
aspart
proteas
cathepsin
inactiv
third
domain
human
kininogen
cystatin
c
suggest
role
cathepsin
regul
activ
cystein
cathepsin
acid
ph
recent
demonstr
hk
regul
endotheli
function
thu
serv
cardioprotect
peptid
studi
show
novel
function
kininogen
regul
angiogenesi
review
like
type
cystatin
kininogen
group
subfamili
cystatin
famili
discoveri
fragment
invari
chain
associ
mhc
classii
molecul
inhibit
cathepsin
l
suggest
appear
new
famili
protein
inhibitor
cystein
cathepsin
find
confirm
discoveri
new
protein
equistatin
isol
sea
anemon
actinia
equina
strongli
inhibit
cathepsin
l
papain
human
cathepsin
determin
amino
acid
sequenc
equistatin
fragment
show
homolog
cystatin
signific
homolog
thyroglobulin
domain
present
prohormon
thyroglobulin
therefor
name
thyropin
suggest
new
group
protein
equistatin
threedomain
protein
ntermin
domain
respons
inhibit
papainlik
proteas
wherea
second
domain
inhibit
cathepsin
thyroglobulin
domain
also
present
sever
function
unrel
protein
thyropin
group
famili
clan
ix
detail
found
recent
review
serpin
typic
inhibitor
serin
protein
also
inhibit
cystein
proteas
crossclass
inhibit
human
squamou
cell
carcinoma
potent
inhibitor
cathepsin
k
l
wherea
hurpin
specif
inhibit
cathepsin
l
similarli
serpin
endopin
select
inhibit
cathepsin
l
compar
elastas
numer
cystatin
cystatinrel
protein
express
tissu
type
human
mammal
sever
gene
includ
cre
cystatinrel
epididym
spermatogen
testatin
cystatint
identifi
lack
highli
conserv
qxvxg
region
crucial
cystein
cathepsin
inhibit
gene
primarili
express
reproduct
tract
suggest
cellspecif
regulatori
function
differ
cystatin
cre
protein
classifi
new
subgroup
within
type
cystatin
review
certainli
group
protein
deserv
detail
investig
order
clarifi
function
geneencod
cystatin
also
found
variou
parasit
organ
function
presum
inhibit
host
proteas
enabl
parasit
develop
cystatin
found
sever
tick
constitut
main
vector
lyme
diseas
usa
europ
twocystatin
transcript
encod
two
differ
gene
tick
ixod
scapulari
express
homolog
salivari
protein
sialostatin
l
sialostatin
strongli
inhibit
almost
equal
cathepsin
l
k
nm
cathepsin
v
k
nm
inhibit
cathepsin
b
x
c
observ
cathepsin
l
collagenolyt
enzym
hydrolyz
ecm
protein
collagen
elastin
shown
collagenolyt
activ
inhibit
chicken
cystatin
consequ
demonstr
sialostatin
l
inhibit
collagenolyt
activ
cathepsin
l
display
antiinflammatori
role
reduc
prolifer
cytotox
tlymphocyt
mani
parasit
organ
contain
specif
parasitederiv
inhibitor
plasmodium
trypanosoma
cruzi
human
filari
nematod
parasit
organ
among
other
although
numer
cystatin
plant
organ
beyond
scope
review
cystatin
stefin
tightrevers
bind
protein
inhibitor
papainlik
cystein
proteas
review
interact
target
enzym
tight
k
valu
fm
determin
interact
cystatin
c
papain
import
step
elucid
molecular
mechan
protein
inhibitor
inhibit
target
enzym
determin
crystal
structur
chicken
cystatin
success
prepar
recombin
human
stefin
b
complex
scarboxymethyl
papain
inhibitor
cystatin
stefin
b
consist
long
fiveturn
fivestrand
antiparallel
sheet
addit
helix
strand
respect
structur
data
provid
strong
evid
three
region
crucial
interact
cognat
enzym
amino
terminu
two
hairpin
loop
expos
first
loop
compris
highli
conserv
qvvag
region
similar
sequenc
qxvxg
flank
either
side
project
ntermin
segment
highli
conserv
second
loop
contain
highli
conserv
protrp
dipeptid
hairpin
loop
amino
terminu
form
tripartit
mainli
hydrophob
wedgeshap
edg
contain
conserv
residu
segment
involv
bind
highli
complementari
activesit
cleft
papain
ntermin
truncat
form
chicken
cystatin
confirm
crucial
import
bind
residu
preced
conserv
residu
hydrophob
sidechain
interact
stabil
complex
cystatin
stefin
complex
interact
subsit
strengthen
complex
papain
consider
howev
report
spite
consider
similar
structur
featur
free
stefin
solut
crystal
homolog
protein
stefin
b
complex
papain
import
differ
region
crucial
protein
bind
five
ntermin
residu
second
bind
loop
similarli
comparison
chicken
cystatin
structur
determin
xray
crystallographi
nmr
show
signific
differ
structur
variabl
segment
polypeptid
chain
find
suggest
bind
cystatinstefin
type
inhibitor
satisfactorili
explain
sole
basi
stefin
bpapain
complex
crystal
structur
stefin
complex
papainlik
exopeptidas
cathepsin
h
show
distinct
differ
ntermin
residu
stefin
adopt
form
hook
slightli
display
cathepsin
h
minichain
distort
small
part
structur
recent
determin
crystal
structur
human
stefin
acathepsin
b
complex
indic
papainlik
part
cathepsin
b
structur
remain
unmodifi
upon
bind
stefin
wherea
occlud
loop
residu
displac
consequ
cathepsin
b
bind
certain
ligand
along
whole
interdomain
interphas
inhibitor
substrat
hand
cathepsin
b
poorli
inhibit
kininogen
due
residu
posit
within
occlud
loop
cathepsin
b
mutant
unlik
mutant
hydrolyz
kininogen
form
tightbind
complex
although
interact
cystatin
target
proteas
primarili
nonspecif
cystatin
abl
discrimin
endoand
exopeptidas
consequ
differ
structur
interact
region
enzym
alreadi
explain
howev
report
mous
stefin
variant
discrimin
papainlik
endopeptidas
cathepsin
l
exopeptidas
cathepsin
b
c
h
interact
exopeptidas
sever
order
magnitud
weaker
compar
human
porcin
bovin
stefin
name
bovin
stefin
b
c
inhibit
rapidli
tightli
endopeptidas
papain
cathepsin
l
pm
rang
wherea
cathepsin
b
poorli
furthermor
shown
human
cystatin
c
stefin
b
chicken
cystatin
strongli
inhibit
endopeptidas
cruzipain
cruzi
k
pm
among
thyropin
potent
inhibitor
human
origin
fragment
inhibit
human
cathepsin
l
k
pm
fragment
isol
complex
cathepsin
l
crystal
structur
determin
structur
fragment
demonstr
new
fold
consist
two
subdomain
connect
disulphid
bond
wedgeshap
threeloop
arrang
fragment
bound
activesit
cleft
cathepsin
l
reminisc
bind
cystatin
thu
demonstr
first
exampl
converg
evolut
observ
cystein
proteas
inhibitor
similar
chagasin
recent
shown
fragment
inhibit
human
cathepsin
v
k
f
mous
cathepsin
l
k
valu
nm
rang
addit
human
cathepsin
l
cruzipain
find
suggest
regul
proteolyt
activ
cystein
cathepsin
fragment
import
widerang
control
mechan
antigen
present
similar
fragment
equistatin
bind
rapidli
tightli
papain
cathepsin
l
lower
affin
cathepsin
b
equilibrium
constant
dissoci
complex
human
cystatin
fragment
target
papainlik
enzym
summar
tabl
affin
k
valu
due
differ
activesit
region
endoand
exopeptidas
discuss
earli
studi
evolut
cystatin
superfamili
base
small
sampl
taxonom
divers
divers
within
cystatin
superfamili
sinc
number
repres
across
mammal
plant
virus
parasit
increas
mainli
due
accumul
mammalian
plant
genom
sequenc
addit
sever
gene
includ
cre
cystatinrel
epididym
spermatogen
testatin
cystatint
relat
cystatin
identifi
lack
consensu
site
import
inhibit
gradual
numer
protein
contain
cystatin
domain
discov
result
challeng
problem
comprehens
evolutionari
classif
detail
analysi
prokaryot
eukaryot
genom
provid
strong
evid
emerg
cystatin
superfamili
ancestor
eukaryot
primordi
gene
duplic
result
two
ancestr
eukaryot
lineag
stefin
cystatin
stefin
remain
intracellular
protein
respons
regul
endogen
protein
turnov
cystatin
gain
signal
peptid
emerg
extracellular
inhibitor
respons
regul
exogen
protein
turnov
involv
hostpathogenparasit
predat
interact
therefor
stefin
may
function
inhibitor
endogen
cystein
proteas
wherea
cystatin
function
inhibitor
exogen
cystein
proteas
noteworthi
intracellular
stefin
conserv
diverg
extracellular
cystatin
moreov
first
diversif
cystatin
occur
ancestor
vertebr
first
ortholog
famili
emerg
indic
function
diversif
occur
multicellular
eukaryot
often
result
loss
ancestr
inhibitori
activ
gain
novel
function
innat
immun
furthermor
observ
distribut
stefin
cystatin
bacteri
genom
limit
suggest
bacteri
stefin
cystatin
may
serv
emerg
inhibitor
thu
enabl
surviv
bacteria
host
defend
host
proteolyt
activ
inhibit
cystein
cathepsin
origin
cystein
cathepsin
believ
particip
exclus
termin
protein
degrad
necrot
autophag
cell
death
howev
nowaday
well
establish
execut
numer
specif
function
particip
import
physiolog
process
mhciimedi
antigen
present
bone
remodel
keratinocyt
differenti
prohormon
activ
other
one
intrigu
field
process
adapt
immun
antigen
process
present
play
major
role
cystein
cathepsin
cathepsin
l
cathepsin
f
human
cathepsin
v
play
crucial
role
degrad
invari
chain
respons
gener
antigen
peptid
mhc
classii
restrict
antigen
present
recogn
cell
found
cathepsin
v
highli
homolog
cathepsin
l
exclus
express
human
thymu
testi
suggest
cathepsin
v
proteas
control
gener
complex
human
thymu
analog
cathepsin
l
mice
observ
inhibit
sever
cystein
cathepsin
fragment
might
import
gener
control
mechan
antigen
present
read
see
sever
physiolog
state
bone
remodel
angiogenesi
prohormon
activ
among
other
cathepsin
endogen
inhibitor
play
import
role
howev
increas
level
cathepsin
express
activ
appear
tabl
interact
repres
lysosom
cystein
proteas
human
cathepsin
cruzipain
papain
select
member
cystatin
famili
human
cystatin
chicken
cystatin
thyropin
fragment
inhibitor
constant
k
human
cystatin
chicken
cystatin
fragment
nd
determin
implic
develop
variou
patholog
condit
neurolog
disord
cardiovascular
diseas
obes
inflammatori
diseas
rheumatoid
arthriti
cancer
among
other
recent
shown
cathepsin
k
defici
induc
structur
metabol
chang
link
learn
memori
deficit
obes
import
risk
factor
variou
metabol
cardiovascular
disord
socal
metabol
syndrom
sever
studi
indic
role
cathepsin
l
k
document
pharmacolog
inhibit
cathepsin
l
result
reduc
bodi
weight
mice
cardiovascular
diseas
crucial
role
play
cystein
cathepsin
strong
elastolyt
collagenolyt
activ
ecm
remodel
consequ
implic
develop
arteri
enlarg
aneurysm
format
cystein
cathepsin
differ
express
variou
stage
atherosclerosi
cathepsin
k
found
first
cathepsin
express
human
atherosclerot
lesion
hand
defici
enzym
mous
model
reduc
atherosclerosi
furthermor
demonstr
cathepsin
b
k
express
cerebr
aneurysm
thu
promot
progress
degrad
ecm
arteri
wall
contrast
upregul
express
cathepsin
cystatin
c
express
reduc
aneurysm
progress
suggest
imbal
cathepsin
inhibitor
may
respons
breakdown
ecm
arteri
wall
ruptur
cerebr
aneurysm
recent
found
leukocyt
cathepsin
defici
result
markedli
alter
plaqu
morpholog
reduc
apoptosi
decreas
collagen
deposit
might
critic
plaqu
stabil
patholog
mechan
respons
degrad
arteri
ecm
still
well
understood
read
review
suggest
sever
genet
disord
due
mutat
gene
cystein
cathepsin
protein
inhibitor
cystatin
genet
studi
reveal
lossoffunct
mutat
cathepsin
c
dppi
gene
result
earlyonset
periodont
palmoplantar
keratosi
characterist
haimmunk
papillonlefevr
syndrom
locat
missens
mutat
suggest
base
structur
studi
disrupt
fold
function
cathepsin
c
cathepsin
k
gene
least
fifteen
known
mutat
human
thu
result
cathepsink
defici
lead
pycnodysostosi
interestingli
mutat
caus
appear
enzym
activ
typei
collagen
preserv
overal
activ
howev
mutat
prevent
format
complex
cathepsin
k
chondroitin
sulfat
crucial
collagenolyt
activ
similarli
genet
disord
also
observ
protein
inhibitor
cystatin
abnorm
format
human
cystatinc
variant
formerli
protein
result
cerebr
haemorrag
amyloidosi
known
hereditari
cystatinc
amyloid
angiopathi
hccaa
review
discoveri
human
protein
inhibitor
cystein
cathepsin
human
cystatin
term
cystatin
c
crucial
understand
format
oligomer
protein
studi
reveal
dimer
nativ
human
cystatin
c
occur
threedimension
domainswap
mechan
suggest
mechan
aggreg
brain
arteri
hccaa
patient
howev
fibril
format
tetram
human
stefin
b
vitro
condit
involv
previous
unknown
process
intramolecular
contact
term
hand
shake
occur
concurr
transtoci
isomer
recent
review
mechan
amyloid
fibril
format
focus
domainswap
mutat
cystatin
b
stefin
b
gene
involv
progress
myoclonu
epilepsi
unverrichtlundborg
diseas
autosom
recess
neurodegen
disord
sever
mutat
detect
stefinb
gene
one
affect
conserv
qvvag
region
crucial
bind
cystein
cathepsin
nevertheless
function
studi
necessari
take
consider
speci
differ
human
mice
cathepsin
f
wide
express
lysosom
enzym
howev
cystein
cathepsin
whose
inactiv
base
cathepsin
f
mice
result
neurodegen
diseas
term
neuron
ceroid
lipofuscinosi
ncl
suggest
possibl
relat
lateonset
ncl
howev
adultonset
patient
reveal
mutat
date
cathepsin
particular
cathepsin
b
first
link
cancer
long
year
ago
clear
cathepsin
import
role
tumor
progress
invas
support
numer
clinic
report
result
experiment
mousecanc
model
elev
cathepsin
express
andor
activ
shown
associ
cancer
progress
number
differ
type
tumor
moreov
level
cathepsin
express
posit
correl
poor
prognosi
cancer
patient
suggest
potenti
prognost
marker
addit
serum
cathepsin
level
posit
correl
metastasi
role
cathepsin
individu
tumorbiolog
process
also
confirm
ex
vivo
use
cellbas
system
cathepsin
b
l
other
shown
promot
migrat
invas
tumor
cell
addit
wellknown
function
associ
ecm
degrad
remodel
tumor
microenviron
cathepsin
suggest
particip
proteolyt
cascad
activ
fig
activ
proupa
proteas
demonstr
vitro
would
thu
potenti
effect
dissolut
tumor
matrix
basement
membran
prerequisit
invas
metastasi
fulfil
function
cathepsin
local
extracellular
space
order
access
bulk
potenti
target
process
affect
tumor
progress
confirm
cathepsin
secret
increas
serum
level
proteas
cancer
patient
detect
despit
extracellular
function
cystein
cathepsin
intracellular
cathepsin
could
particip
tumor
progress
affect
process
act
protumorigen
antitumorigen
exampl
intracellular
protumorigen
activ
cathepsin
could
particip
intracellular
collagen
degrad
moreov
role
cystein
cathepsin
normal
malign
extracellular
matrix
degrad
agreement
find
endocyt
transmembran
glycoprotein
upa
receptorassoci
protein
direct
collagen
iv
lysosom
deliveri
degrad
hand
cathepsin
recent
attract
consider
attent
potenti
mediat
program
cell
death
apoptosi
key
process
cancer
develop
progres
howev
evid
accumul
multipl
scenario
cystein
cathepsin
promot
cell
death
exampl
releas
lysosom
could
engag
mitochondri
pathway
apoptosi
activ
caspas
indirectli
degrad
antiapoptot
famili
member
proteolyt
activ
bid
fig
moreov
abil
cleav
xiap
suggest
involv
control
apoptosi
upstream
downstream
mitochondria
anoth
level
complex
introduc
fact
proteolyt
activ
cystein
cathepsin
regul
endogen
protein
inhibitor
stefin
cystatin
serpin
found
higher
level
cathepsin
inhibitor
differ
type
cancer
correl
favor
prognosi
cancer
patient
hand
increas
concentr
stefin
bodi
fluid
carcinoma
patient
correl
significantli
shorter
surviv
time
although
higher
level
cathepsin
inhibitor
may
counterbal
upregul
cystein
cathepsin
role
cancer
remain
poorli
defin
call
investig
perform
addit
evid
confirm
import
role
cathepsin
cancer
progress
provid
use
cathepsinsknockout
technolog
transgen
cancer
model
small
anim
year
two
research
group
independ
shown
effect
major
cathepsincathepsin
deplet
tumor
develop
progress
metastasi
two
murin
cancer
model
pancreat
islet
cell
carcinoma
ii
mmtvpymt
mous
mammari
cancer
summar
tabl
deplet
cathepsin
b
cancer
model
result
significantli
reduc
tumor
burden
delay
develop
highgrad
carcinoma
furthermor
model
signific
decreas
prolifer
tumor
cell
detect
prolifer
index
reduc
mice
mice
week
old
contrast
model
differ
tumor
vascular
apoptosi
detect
mmtvpymt
model
breast
cancer
confirm
followup
report
moreov
shown
genet
ablat
cathepsin
b
primari
mmtvpymt
tumor
cell
induc
membran
transloc
anoth
carboxypeptidas
cathepsin
x
restor
invas
capabl
tumor
cell
annihil
effect
princip
proteas
delet
level
lung
metastasi
first
report
cathepsincompens
effect
confirm
use
doubl
cathepsin
b
x
knockout
mice
cross
mmtvpymt
mous
model
provid
evid
synergist
anticanc
effect
carboxypeptidas
despit
import
role
cathepsin
tumor
cell
increas
bodi
evid
confirm
upregul
cystein
cathepsin
cell
tumor
microenviron
macrophag
cancer
state
current
view
product
microenviron
therefor
new
technolog
enabl
target
tumor
microenviron
would
repres
effici
approach
cancer
prevent
intervent
inde
technolog
recent
provid
develop
novel
target
drugdeliveri
system
enabl
target
tumor
microenviron
moreov
target
smallmolecul
inhibitor
cystein
cathepsin
potent
treatment
pancreat
islet
tumor
mous
model
lack
efficaci
mous
breastcanc
model
due
poor
bioavail
compound
respect
antitumor
therapi
use
prove
success
result
signific
reduct
tumor
growth
therebi
prove
concept
stroma
target
cathepsin
potent
target
cancer
treatment
therefor
applic
select
inhibitor
cathepsin
offer
new
possibl
diagnosi
treatment
human
diseas
rheumatoid
arthriti
ra
character
chronic
synovi
joint
inflamm
infiltr
activ
cell
apc
dendrit
cell
macrophag
involv
progress
destruct
articular
cartilag
eventu
lead
loss
joint
function
addit
metalloproteas
collagenas
aggrecanas
lysosom
cystein
cathepsin
b
l
identifi
synovi
fluid
furthermor
involv
cathepsin
b
l
bone
degrad
demonstr
select
inhibit
enzym
addit
express
potent
ecm
degrad
enzym
cathepsin
k
found
synovi
fibroblast
ra
patient
correl
fig
mechan
cystein
cathepsin
involv
cancer
progress
extracellular
cystein
cathepsin
promot
tumor
progress
initi
proteolyt
cascad
result
activ
urokinasetyp
plasminogen
activ
upa
matrix
metalloproteinas
mmp
plasminogen
collect
activ
proteas
includ
cystein
cathepsin
degrad
compon
extracellular
matrix
promot
tumor
progress
metastasi
degrad
celladhes
protein
eg
ecadherin
would
addit
increas
dissemin
abil
tumor
cell
altern
transloc
cytosol
cystein
cathepsin
shown
act
initi
proteas
lysosomemedi
cell
death
degrad
antiapoptot
famili
member
proteolyt
activ
bid
engag
mitochondri
pathway
apoptosi
sever
diseas
report
interest
find
chondroitin
sulfat
found
synovi
fluid
stabil
cathepsin
k
activ
subsequ
increas
collagenolyt
activ
recent
report
neither
cathepsin
b
cathepsin
h
serum
level
associ
diseas
progress
destruct
associ
high
serum
level
inhibitor
stefin
b
cystatin
c
addit
found
cathepsin
b
significantli
elev
cathepsin
detect
synovi
fluid
ra
patient
significantli
elev
level
cathepsin
consist
critic
role
immun
respons
recent
develop
medic
treatment
may
contribut
effect
safe
treatment
rheumatoid
arthriti
ostheoarthr
use
specif
inhibitor
past
two
decad
wit
tremend
advanc
understand
properti
structur
cystein
cathepsin
endogen
protein
inhibitor
cystatin
although
knowledg
emerg
recent
understand
basic
biolog
protein
normal
patholog
condit
constantli
improv
although
addit
rule
yet
precis
establish
applic
genom
proteom
approach
identifi
new
substrat
individu
cathepsin
uncov
new
role
enzym
vivo
new
strategi
vivo
imag
cystein
cathepsin
activ
design
select
enzym
activitybas
probe
progress
comput
approach
base
threedimension
structur
domaindomain
interact
involv
cystein
cathepsin
protein
inhibitor
provid
comprehens
view
biolog
system
explor
insight
cystein
cathepsin
biolog
human
new
emerg
therapi
variou
diseas
cancer
inflammatori
diseas
neurolog
disord
cardiovascular
diseas
parasit
diseas
develop
high
probabl
incorpor
clinic
trial
